Bao Xiaomin, Wang Yan, Li Bin, Peng Liang, Ouyang Bin, Ng Chew Lip, Zhuo Yongshi, Wang Qiumin, Li Chunwei, Li Jian
Department of Otorhinolaryngology, The First Affiliated Hospital of Sun Yat-sen University, Guangdong, Guangzhou, China.
Department of Radiation Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangdong, Guangzhou, China.
Heliyon. 2023 Dec 12;10(1):e23554. doi: 10.1016/j.heliyon.2023.e23554. eCollection 2024 Jan 15.
We aimed to investigate the clinical and dosimetric factors associated with radiation-induced rhinosinusitis, and further elucidate the optimal dose-volume constraints for nasopharyngeal cancer patients who underwent volumetric-modulated arc therapy (VMAT).
A retrospective review of 196 nasopharyngeal carcinoma (NPC) patients who underwent definitive VMAT between August 2018 and May 2021 was conducted. Both clinical and dose-volume histogram (DVH) data of NPC patients without rhinosinusitis at baseline were selected for analysis.
The cumulative incidence of post-RT rhinosinusitis at the 3-, 6-, 9-, and 12-months, and >1 year were 29.6 %, 41.3 %, 42.9 %, and 45.4 %, and 47.4 %, respectively. Nasal irrigation was negatively associated with post-RT rhinosinusitis (p < 0.001). Higher cumulative incidences of maxillary and ethmoid sinusitis were associated with V70 > 1.16 % and >1.00 %, respectively (p = 0.027 and p = 0.002). Sphenoid sinusitis was more frequent when Dmax(maxillary sinus) exceeded 69.2Gy (p = 0.005).
Regular nasal irrigation may reduce the development of rhinosinusitis. Dose-volume constraints of V70 and Dmax to the maxillary sinus are suggested for VMAT planning. Patients exceeding these thresholds should be closely monitored and potentially offered preventative interventions within 3-6 months post-RT.
我们旨在研究与放射性鼻窦炎相关的临床和剂量学因素,并进一步阐明接受容积调强弧形放疗(VMAT)的鼻咽癌患者的最佳剂量-体积限制。
对2018年8月至2021年5月期间接受确定性VMAT的196例鼻咽癌(NPC)患者进行回顾性研究。选择基线时无鼻窦炎的NPC患者的临床和剂量体积直方图(DVH)数据进行分析。
放疗后3个月、6个月、9个月、12个月及>1年时放射性鼻窦炎的累积发生率分别为29.6%、41.3%、42.9%、45.4%和47.4%。鼻腔冲洗与放疗后鼻窦炎呈负相关(p<0.001)。上颌窦炎和筛窦炎累积发生率较高分别与V70>1.16%和>1.00%相关(p=0.027和p=0.002)。当Dmax(上颌窦)超过69.2Gy时,蝶窦炎更常见(p=0.005)。
定期鼻腔冲洗可能减少鼻窦炎的发生。建议在VMAT计划中对上颌窦的V70和Dmax进行剂量-体积限制。超过这些阈值的患者应密切监测,并可能在放疗后3至6个月内进行预防性干预。